首页|转录组学数据挖掘结合"临床-动物"研究验证识别激素性股骨头坏死全病程的证素标志基因

转录组学数据挖掘结合"临床-动物"研究验证识别激素性股骨头坏死全病程的证素标志基因

扫码查看
采用转录组数据挖掘与实验验证相结合的研究策略,识别表征激素性股骨头坏死(SONFH)痰、瘀、虚证素的标志基因。首先,利用项目组前期临床转录组学检测所得SONFH痰瘀阻络证、经脉痹阻证、肝肾亏虚证共性差异表达基因集,整合差异表达趋势分析与功能挖掘,分别预测出表征痰、瘀、虚证素的候选标志基因集。再利用来源于临床SONFH患者的全血样本、SONFH大鼠的全血和受累股骨头组织样本,采用实时荧光定量PCR(qPCR)技术检测上述候选标志基因的表达量;进一步,采用受试者工作特征曲线(ROC)法,客观评价上述候选标志基因的辨证效能。转录组数据分析结果显示,痰证素候选标志基因为超长链脂肪酸延伸酶6(ELOVL6),瘀证素候选标志基因为锚蛋白1(ANK1)、血型糖蛋白A/B(GYPA/B)、Rh相关糖蛋白(RHAG),虚证素候选标志基因为溶质载体家族2(促进葡萄糖转运体)成员1(SLC2A1)、胃口素(STOM)。qPCR验证结果显示,与非SONFH组比较,ELOVL6在痰瘀阻络证患者外周血中的表达量最低(P<0。05);与正常对照组比较,其在SONFH大鼠造模4周外周血和受累股骨头组织中的表达量最低(P<0。01),且对大鼠造模4周的辨证效能(AUC=0。850,P=0。006)优于其他造模时间点(8、12、16、21 周 AUC 分别为 0。689、0。766、0。588、0。662)。与非 SONFH 组比较,ANK1、GYPA、RHAG 均在经脉痹阻证患者外周血中表达最低(P<0。05);与正常对照组比较,其在SONFH大鼠造模12周外周血和受累股骨头组织中的表达量最低(P<0。05,P<0。01),且对大鼠造模 12 周的辨证效能(ANK1:AUC=0。855,P=0。006;GYPA:AUC=0。861,P=0。012;RHAG:AUC=0。854,P=0。009)优于其他造模时间点(4、8、16、21 周,ANK1 的 AUC 分别为 0。630、0。658、0。657、0。585;GYPA 的 AUC 分别为 0。646、0。573、0。691、0。617;RHAG 的 AUC 分别为 0。592、0。511、0。515、0。536)。与非 SONFH 组比较,SLC2A1和STOM均在肝肾亏虚证患者外周血中表达量最低(P<0。05);与正常对照组比较,其在SONFH大鼠造模21周外周血和受累股骨头组织中的表达量最低(P<0。05,STOM在大鼠外周血中表达量与正常对照组间的差异无统计学意义除外),且SLC2A1对大鼠造模21周的辨证效能(AUC=0。806,P=0。009)优于其他造模时间点(4、8、12、16周AUC分别为0。520、0。580、0。741、0。774),STOM的辨证效能无意义。综上,SONFH中痰证素的标志基因为ELOVL6,瘀证素的标志基因为ANK1、GYPA和RHAG,虚证素的标志基因为SLC2A1,有助于从基因水平揭示SONFH痰、瘀、虚证素的生物学内涵。
Transcriptome data mining combined with clinical and animal experiments for identification of syndrome element marker genes during entire course of steroid-induced osteonecrosis of femoral head
A research strategy combining transcriptome data mining and experimental verification was adopted to identify the marker genes characterizing the syndrome elements of phlegm,stasis,and deficiency in steroid-induced osteonecrosis of the femoral head(SONFH).Firstly,the common differentially expressed gene sets of SONFH with the syndromes of phlegm-stasis obstructing collaterals,vessel obstruction,and liver-kidney deficiency were obtained from the clinical transcriptomic analysis of a previous study.The differential expression trend analysis and functional gene mining were then employed to predict the candidate marker gene sets representing phlegm,stasis,and deficiency.The whole blood samples from SONFH patients,whole blood samples from SONFH rats,and affected femoral head tissue samples were collected for qPCR,which aimed to determine the expression levels of the candidate marker genes mentioned above.Furthermore,the receiver operating characteristic curve(ROC)was established to objectively evaluate the syndrome differentiation effectiveness of the candidate marker genes mentioned above.The transcriptome data analysis results showed that the candidate marker genes for phlegm was ELOVL fatty acid elongase 6(ELOVL6),and those for stasis were ankyrin 1(ANK1),glycophorin A/B(GYPA/B),and Rh-associated glycoprotein(RHAG).The candidate marker genes for deficiency were solute carrier family 2 member 1(SLC2A1)and stomatin(STOM).The qPCR results showed that compared with that in the non-SONFH group,ELOVL6 had the lowest expression level in the peripheral blood of the SONFH patients with the syndrome of phlegm-stasis obstructing collaterals(P<0.05).Compared with that in the normal control group,ELOVL6 had the lowest expression level in the peripheral blood and affected femoral head tissue of SONFH rats modeled for 4 weeks(P<0.01),and it showed better syndrome differentiation effectiveness of rats modeled for 4 weeks(AUC=0.850,P=0.006)than at other modeling time points(8,12,16,and 21 weeks,AUC of 0.689,0.766,0.588,and 0.662,respectively).Compared with that in the non-SONFH group,the expression levels of ANK1,GYP A,and RHAG were the lowest in the peripheral blood of SONFH patients with the vessel obstruction syndrome(P<0.05).The expression levels of the three genes were the lowest in the peripheral blood and affected femoral head tissue of SONFH rats modeled for 12 weeks(P<0.05,P<0.01),and their syndrome differentiation effectiveness in the rats modeled for 12 weeks(GYPA:AUC=0.861,P=0.012;ANK1:AUC=0.855,P=0.006;RHAG:AUC=0.854,P=0.009)was superior to that for 4,8,16,and 21 weeks(GYPA:AUC=0.646,0.573,0.691,and 0.617,respectively;ANK:AUC1=0.630,0.658,0.657,and 0.585,respectively;RHAG:AUC=0.592,0.511,0.515,and 0.536,respectively).Compared with the non-SONFH group,both SLC2A1 and STOM had the lowest expression levels in the peripheral blood of patients with the syndrome of liver and kidney deficiency(P<0.05).Compared with the normal control group,their expression levels were the lowest in the peripheral blood and affected femoral head tissue of SONFH rats modeled for 21 weeks(P<0.05,except STOM in the peripheral blood of rats).Moreover,the syndrome differentiation effectiveness of SLC2A1 in the rats modeled for 21 weeks(AUC=0.806,P=0.009)was superior to that for 4,8,12,and 16 weeks(AUC=0.520,0.580,0.741,0.774,respectively),and STOM was meaningless in syndrome differentiation.In summary,the candidate marker gene for phlegm in SONFH is ELOVL6;the candidate marker genes for stasis are GYP A,RHAG,and ANK1;the candidate marker gene for deficiency is SLC2A1.The results help to reveal the biological connotations of phlegm,stasis,and deficiency in SONFH at the genetic level.

steroid-induced osteonecrosis of the femoral headphlegmstasisdeficiencysyndrome elementmarker gene

李群、胡智星、张彦琼、贾雁、杨超、王丽丽、王佳琳、严倩倩、陈卫衡、林娜、刘春芳

展开 >

中国中医科学院中药研究所,北京 100700

北京中医药大学第三附属医院,北京 100029

激素性股骨头坏死 证素 标志基因

国家自然科学基金重点项目国家自然科学基金面上项目北京市自然科学基金面上项目中国中医科学院科技创新工程项目

82030122819738887232304CI2021A03808

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(5)
  • 38